EMAIL THIS PAGE TO A FRIEND

Indian journal of pediatrics

Miltefosine: an oral drug for visceral leishmaniasis.


PMID 15053378

Abstract

Miltefosine, a phosphocholine analogue originally developed as antimalignant drug, has been found to be highly active against leishmania in vitro and animal model. Based on these experiences this drug was tried against human visceral leishmaniasis and found to be highly effective and achieved 97% and 94% cure in phase 2 and phase 3 trial in children.